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Abstract 
Background 
Post-operative cognitive dysfunction (POCD) occurs frequently after surgery, and is related to 
dementia and premature death. Obesity increases the risk of late-life cognitive impairment, 
but little is known about its role in POCD. We conducted a systematic review and meta-
analysis of studies on the association between obesity and risk of POCD.  
Methods 
PubMed and the Cochrane Library were systematically searched. Studies were included if 
they had prospective designs, reported on human adults undergoing surgery, if cognitive 
function was measured pre- and post-surgery, if obesity, body mass index (BMI) and/or body 
weight were ascertained, and if associations with POCD were reported as relative risks or 
odds ratios. Underweight, weight loss, and post-operative delirium were not considered. 
Results 
Inclusion criteria were met by six articles. Samples totaled 1432 older patients (mean age ≥62 
years) who were followed up for 24 hours to twelve months after surgery. Analysis of studies 
with obesity defined as a categorical measure found a non-significantly higher risk of POCD 
among persons with BMI>30 kg/m
2 versus ≤30 kg/m2 (RR 1.27; 95% CI 0.95, 1.70; p=0.10). 
No such associations were found for studies that analyzed BMI or body weight continuously 
as predictors of POCD (RR 0.98 per kg/m
2
; 95% CI 0.93, 1.03, p=0.45; RR 0.99 per kg; 95% 
CI 0.89, 1.09; p=0.83, respectively).  
Conclusions 
Few studies have addressed the topic, and the results of these studies provide only limited 
support for an increased risk of POCD in patients who are obese. Further large-scale, 
prospective investigations are necessary for clarification.  
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Introduction 
Post-operative cognitive dysfunction (POCD) is a frequent condition that may occur after any 
type of surgery. POCD broadly refers to a “deterioration in cognition temporally associated 
with surgery” [1]. In contrast to post-operative delirium (POD), POCD is characterized by 
intact consciousness and a more subtle onset [2], and it is thought to be caused by distinct 
pathology. POCD is considered as a transient condition [3], but disease progression and 
resulting cognitive trajectories of POCD vary substantially between individuals [4] and 
depend on the time since surgery. Overall incidence rates in older age groups range between 
10-38% [5-8] within the first 2 to 3 months and 3-24% at 6 to 12 months after surgery [7, 9, 
10]. Further, POCD appears to increase the risk of subsequent dementia diagnosis as well as 
premature death [3, 6, 11, 12]. The etiology and pathophysiology of POCD are relatively 
unclear, and only a few risk factors have been identified to date, including higher age and pre-
existing cognitive impairment [7, 13, 14]. In view of the high rate at which surgical 
procedures are performed in older adults [15], the identification of risk factors for POCD 
urgently warrants detailed investigation. Firm knowledge of its risk factors will enable 
identification of at-risk patients with the potential for tailoring of post-operative support and 
care according to individual risk. Further, a clear definition of its risk factors could guide the 
designs of studies including clinical trials that will ultimately shed light on the causal 
mechanisms underlying POCD. 
Obesity is an established risk factor for a number of chronic diseases, most notably type 2 
diabetes, cardiovascular disease, and certain types of cancer [16, 17]. Obesity has also been 
linked to cognitive impairment in the general population. For instance, a recent systematic 
review found that obesity at midlife increases dementia risk by 64% [18]. Obesity also 
increases the risk of hospitalization [19]; however, it is unclear whether obesity is a risk factor 
for POCD. Obesity is a major public health problem today in most countries of the world [20-
22]. In the EU, approximately 40-50% of men and 25-35% of women are overweight (defined 
as a body mass index, BMI, between 25.0 and 29.9 kg/m
2
) and an additional 15–25% of men 
and 15–25% of women are obese (BMI≥30 kg/m2) [23]. Given the high prevalence of obesity, 
even weak associations with POCD could result in high attributable risks, which would be of 
substantial public health importance. We are not aware of any review that has assessed the 
evidence for an association of obesity with risk of POCD. We therefore aimed to 
systematically review the research literature on studies that have investigated the association 
of obesity with risk of cognitive dysfunction following surgery. For brevity, the term ‘obesity’ 
is used throughout this article to denote obesity, a higher BMI or a higher body weight.  
 
Materials and Methods 
Systematic search strategy 
A literature search for relevant articles was performed in accordance with MOOSE and 
STROBE guidelines [24, 25] by one investigator (IF). The titles, abstracts and keywords of 
the PubMed database and Cochrane Database of Systematic Reviews were searched from 
their respective inception onwards for the following terms: (“obes*” OR “BMI” OR “body 
mass index” OR “waist*” OR “body weight” OR “overweight” OR “body size”) AND 
((“post-operative cognit*” OR “postoperative cognit*” OR “POCD”) OR ((“surgery” OR 
“operation”) AND (“cognit” OR “intelligence” OR “MMSE” OR “Mini Mental” OR 
“dementia” OR “Alzheim*” OR “mild cognitive impairment” OR “MCI”))). No language 
restrictions or other search filters were applied. All abstracts of articles identified in the search 
were screened. If articles were deemed potentially relevant on the basis of their abstracts due 
to possibly matching inclusion criteria (e.g., reporting data both on BMI and POCD), full 
texts were accessed to formally compare against these criteria. Reference lists of articles that 
matched inclusion criteria and of review articles were additionally hand-searched. The final 
search was performed on 24
th
 September 2015.  
Study selection 
Articles were included in the review if full-text assessment determined that the following 
criteria were met: i) original article reporting on humans aged ≥18 years, ii) prospective study 
of patients undergoing surgery, iii) cognitive function determined at least once pre-surgery 
and once post-surgery using performance-based cognitive assessment tools, iv) measurement 
of any anthropometric parameter (AP) prior to surgery, v) and reporting of their association 
with cognitive change in standardized form either as odds ratios or relative risks (both termed 
RR for the purpose of the present review). Studies on underweight were not considered as 
these exceeded the interest of the present article. Review articles and studies on diagnosed 
delirium were excluded. The use of the label ‘POCD’ was not required: As definition and 
measurement of POCD vary between studies [26], any operationalization of change in 
cognitive function between pre-surgery and post-surgery assessments qualified for inclusion.  
 
Data extraction 
Data on study design, location, number of patients included in the analysis, proportion of 
males, age, type of surgery and anesthesia, assessment methods for AP and cognitive 
function, prevalence of obesity, incidence of POCD, RR statistics, reference categories, and 
adjustment variables (if available) were extracted. We extracted fully adjusted analyses unless 
no adjustment was applied. If any essential information was unreported in an article, the first 
author of the article was contacted by email. That way, unreported information on the 
definition of ‘obesity’ was obtained for one article [27]. If a number of articles reported on a 
single study [28], articles with data on the longest follow-up period were selected to avoid 
duplicate inclusion of samples. Where several waves of follow-up were reported in a single 
article, the longest follow-up period was selected. Author contact to obtain information on 
‘non-significant’ findings at 3-month follow-up was unsuccessful for one article, and so data 
for 7-day follow-up were used [29]. For another article, risk estimates did not appear to match 
the reported 95% CI [27]. The issue was not resolved in personal correspondence, and so we 
opted to take the reported 95% CI at face value to allow meta-analysis. 
Quality assessment  
Quality of reporting was assessed by one investigator (IF) using the STROBE statement 
checklist for cohort studies, a 22-item list addressing the reporting of objectives, methods, 
interpretation and potential biases [30]. Each positively evaluated item of the checklist was 
assigned a score of 1 (maximum score 22). As the checklist does not address methodological 
study quality [31], no exclusion based on these scores was applied.  
 
Data synthesis and analysis 
Extracted data were tabulated and were entered into Review Manager 5.3 (Cochrane, 2014) to 
calculate summary estimates of RR (95% CI) using inverse variance fixed effect models, and 
to derive standard I
2
 as an index of statistical heterogeneity among studies [32].  
Results 
Study characteristics 
The search resulted in 286 articles in PubMed and 1 article in the Cochrane Library (see 
Figure 1). All titles and abstracts were screened. Exclusion at this stage resulted from articles 
clearly failing inclusion criteria (and therefore being not deemed potentially relevant). This 
was most commonly due to articles reporting on animal studies or on unrelated topics such as 
‘cognitive restraint’ or ‘cognitive behavioral therapy’ for weight loss. For 48 articles that 
passed the stage of abstract screening, full texts were accessed. Hand-searching of reference 
lists of relevant articles and review articles, and an independent online search resulted in 10 
further potentially relevant original articles for which full texts were also accessed [29, 33-
41]. The full texts of a total of N=58 original articles were therefore compared against 
inclusion criteria. All were in English language except 2 articles in Chinese, which were 
considered with help from a native speaker. Forty-seven of the 58 articles did not meet 
inclusion criteria due to failing to associate AP with POCD (including studies of bariatric 
surgery) (n=32), or due to cross-sectional study designs or analyses (n=5), lack of cognitive 
data (n=3), lack of reporting of RR (n=3), focus on underweight or weight gain surgery (n=2), 
case study (n=1) or due to describing the methodology and design of a future study (n=1). 
Within 5 [35-39] and within 2 articles [40, 42], we found that these articles appeared to report 
on identical patient samples. We therefore selected one article for each patient sample for 
inclusion [36, 42]. Thus, a total of N=6 articles remained for analysis.  
 
Across studies, a total of 1432 patients were included (see Table 1). In one study, the 
reporting quality was limited because it was published as a three-page brief report [27]. The 
remaining five studies were exploratory in nature. Sample size ranged from 36 [27, 36, 42] to 
585 [29, 41]. Studies stemmed from China, Japan, USA, Australia, and Spain, with follow-up 
periods of between 1 day and 12 months (median follow-up 7 days, interquartile range 7 days 
– 6 months). Publication dates spanned 2005 to 2015. Patients underwent heart surgery, 
carotid endarterectomy, or total hip replacement. Mean sample age ranged from 62 to 75 
years (where reported). All studies except one study [36] included males and females at 
approximately equivalent proportions and none stratified the analyses by sex. All except one 
study [27] excluded patients with diagnosed or suspected dementia, or 
neurological/psychiatric disorders at baseline. Five studies applied detailed batteries of 
cognitive tests [27, 29, 36, 41, 42] of which four compared cognitive changes in the patient 
group to reference or control groups to define POCD [27, 29, 41, 42]. One study used raw 
change on the Mini Mental State Examination [43], a brief cognitive screening instrument 
[44]. In all studies, POCD was a dichotomous outcome.  
Findings of included studies and meta-analysis 
Three of the six studies compared obese (BMI>30 kg/m
2
) with non-obese patients (BMI≤30 
kg/m
2
 ) [27, 41, 42], two studies used body weight as a continuous predictor [36, 44] and one 
study used BMI as a continuous predictor [29]. Individual effect sizes for all studies and 
pooled effect sizes for the two groups with ≥2 studies (allowing subgroup analysis) are shown 
in Figure 2. The funnel plot including all studies is shown in Figure 3.  
The study on BMI as a continuous predictor reported no association with risk of POCD at 7 
days after surgery with statistically significant, independent contributions by age and type of 
surgery controlled for (RR per kg/m
2
 increase 0.98; 95% CI 0.93, 1.03; p=0.45; see Figure 2) 
[29]. When the results of two studies that assessed body weight as a continuous predictor of 
POCD at 7-day and 6-month follow-up, respectively, were pooled [36, 44], we also found no 
significant association with risk of POCD (RR per kg increase 0.99; 95% CI 0.89, 1.09; 
p=0.83; see Figure 2). Both of these studies had adjusted for a range of sociodemographic and 
clinical covariates. Of the three studies that categorized patients according to obesity, two 
found that BMI>30 kg/m
2
 at baseline was statistically significantly associated with an 
increased risk of POCD compared to BMI<30 kg/m
2
 [27, 42]. In the larger of these studies, 
with a sample size of 75, analyses were controlled for age, diabetes and APOEe4 status. Here, 
BMI>30 kg/m
2
 was associated with a 24-fold increased risk of POCD at 1 month after carotid 
endarterectomy surgery compared to BMI<30 kg/m
2
 [42]. A smaller study of 36 patients that 
did not apply adjustment revealed a 2.14-fold increased risk of POCD at 12 months following 
cardiac surgery for patients with BMI>30 kg/m
2 versus ≤30 kg/m2 [27]. One relatively large 
investigation with 1-day follow-up, in contrast, reported no such findings even in unadjusted 
analyses [41]. When we pooled the relative risks across these three studies, the association of 
obesity (BMI>30 kg/m
2
) with risk of POCD was statistically not significant at the 5% level 
(RR 1.27; 95% CI 0.95, 1.70; p=0.10). Statistical heterogeneity between the three studies was 
moderate (Chi
2
 (2) = 8.84; I
2
=77%; p=0.01; see Figure 2).  
Discussion 
Here, we set out to combine the existing evidence on obesity and risk of post-operative 
cognitive dysfunction (POCD) but were restricted in our endeavour by the small number of 
studies conducted on the topic, by heterogeneity between studies and by overall poor study 
quality. Though further research is urgently needed, our findings at present offer only limited 
support for a role of obesity as increasing the risk of POCD. 
Obesity is well-established as a risk factor for later cognitive impairment in the general 
population [18], and an extension of the relationship to impairment occurring after the ‘insult’ 
of surgery appears plausible. It would also be consistent with investigations in humans and 
animal models that have identified the metabolic syndrome, of which obesity is a key 
component, as increasing the risk for post-operative cognitive deficits [45-48]. Though the 
present marginal association of obesity with POCD across studies may indicate that the 
association is weak but global in nature, a masking of effects by the substantial degree of 
heterogeneity between studies is also possible. Any specific study characteristics that do not 
lead to associations of obesity with POCD may have rendered findings statistically non-
significant when effects were pooled across all studies included here. Further, as body weight 
has a U-shaped relationship with cognitive impairment [18], we speculate whether the failure 
to detect statistically significant associations in the present analysis were caused partly by the 
fact that the non-obese groups may have included underweight patients. Their inclusion may 
have led to an underestimation of the effect sizes for the association of obesity and POCD. 
None of the studies reviewed here reported the prevalence of underweight in their total 
samples or mean BMI in non-obese groups (which would provide some indication of the 
weight characteristics of these groups), and so potential confounding by this factor leaves 
scope for future re-analysis of their data. However, a role of obesity in POCD finds support in 
one additional study that strictly failed to meet inclusion criteria of the present analysis due to 
a lack of reporting of findings as relative risks: In that study, which did not apply any 
statistical adjustment, a group with POCD 7 days after surgery had a 0.7 standard deviation 
higher mean body weight compared with a cognitively unimpaired group [33].  
 
The overall evidence is therefore inconclusive at present and warrants resolution in further 
investigations. Any future confirmation of links between obesity and an increased risk of 
cognitive dysfunction following surgery would have far-reaching implications. For instance, 
ascertainment of obesity, which is easy, cheap and quick even when precise measurements are 
unavailable, could prove useful for risk prediction in clinical management of older adults. In 
cases where surgery is essential, risk stratification could allow early introduction of support 
systems for at-risk patients. Obesity is also relatively unique as a risk factor in that although it 
is not modifiable at the time when patients present for surgery, it is modifiable in the long 
term, so that – should any observational evidence of associations with POCD prove causal – it 
could become a viable target for intervention. Briefly, potential underlying mechanisms, some 
of which could be targeted, include effects of circulating correlates of adipose tissue such as 
cortisol [49] or inflammatory markers [50], which have both been identified as risk factors for 
cognitive impairment in epidemiological research [51, 52]. Blood-brain barrier function also 
appears to be compromised in obesity [53] which may affect susceptibility to cognitive 
impairment [54] and so potentially to POCD. Causality is by no means certain, however, as 
confounding of obesity relationships with POCD by other factors, such as dyslipidemia, 
glycemia or pre-morbid ability, may be possible [55]. For instance, a lower pre-morbid ability 
is well-established as a risk factor for the metabolic syndrome [56] and is also a candidate risk 
factor for POCD [6]. The selection of adjustment variables to control for potential 
confounding was inconsistent across the studies included in the present analysis, and was 
typically based on univariable associations with POCD or a ‘throw in everything’ approach, 
rather than plausible underlying mechanisms or previous research. The role of confounders in 
the present pooled analysis of obesity and POCD risk is therefore entirely uncertain.  
Strengths of the present review include wide inclusion criteria that allowed any definition of 
obesity and POCD. Generalizability of our findings was limited by the small number of 
articles, by overall poor study quality that often included small sample sizes, and by 
heterogeneity in study designs and in characteristics of patient samples. This complicated 
pooling of effects as well as assessment of contributions of any between-study differences in 
terms of surgery type, sample age or cognitive domain tested to the present findings. For 
instance, surgery type may itself influence the risk of POCD, though the evidence is not 
entirely clear as yet [6, 29, 57], and so could also play a role in associations of obesity with 
POCD.  
 
Clearly, larger observational studies are needed to address the role of obesity on risk of POCD 
across diverse, well-characterized patient groups and to strategically assess the independence 
versus dependence of the relationship from other candidate risk factors. We further cannot 
rule out influences of delirium on cognitive status in studies with brief follow-up periods (e.g., 
[41]) on our findings. . A majority of investigations that we included in our analysis were 
exploratory, which hindered identification of articles, and our search strategy did not include 
any domain-specific terms. Therefore, readers should be aware that we may not have been 
successful in the identification of all relevant articles.  
All of the included investigations used body weight or BMI to assess obesity. Studies 
conducted over the past years have shown that waist circumference as a marker of abdominal 
body fat distribution may be more closely related to risk of many chronic diseases and to 
mortality than BMI [17, 58]. Future studies on the role of obesity for risk of POCD should 
therefore additionally include the measurement of waist circumference to define the “obesity” 
phenotype [59]. Also, the potential effect of obesity at different times of the life-span on risk 
of POCD deserves investigation [18]. 
 The definition of POCD as a dichotomous outcome based on underlying test batteries is 
somewhat arbitrary and may lead to loss of statistical power as compared to continuous 
outcomes in individual studies [60]. Future studies should therefore consider to also 
operationalize surgery-associated cognitive decline as a continuous outcome. Finally, it may 
be useful to assess potential associations of obesity with selective impairment on individual 
cognitive domains under careful consideration of the issue of multiple statistical testing.  
In conclusion, in this systematic review we found limited evidence for an association of 
obesity and risk of POCD. We identified only six studies that have addressed this topic of 
which most had small sample sizes. The overall limited evidence of an increased risk of 
POCD in patients who are obese is tentative and preliminary at present, and may be affected 
by the inclusion of underweight patients. Large prospective studies are necessary to clarify 
whether POCD may or may not be added to the long list of health risks associated with 
obesity. 
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 Table 1: Summary of included studies. 
Authors, 
year, 
location 
N in 
analysis 
 
% 
male 
Type of 
surgery, 
anesthesia 
Mean 
age ± 
SD in 
years 
Follow
-up  
Cognitive  
Assessment  
Definition/ 
frequency of 
POCD 
AP exposure 
variable  
Adjustment 
variables 
AP exposure 
and risk of 
POCD  
Reporting 
quality 
score* 
Heyer et 
al. (2005) 
[42] 
 
USA 
75 61 Carotid 
endarterectomy. 
 
General 
anesthesia. 
69 ± 
9  
30 days Five detailed 
neuropsychological 
tests (Boston 
Naming Test; 
Halstead-Reitan 
Trails A; Halstead-
Reitan Trails B; 
Controlled Oral 
Word Association 
Test; Rey Complex 
Figure Test). 
 
For each test, 
calculation of z 
scores:  (Change 
score – mean 
change 
score of 
controls)/SD of 
change score of 
controls. Control 
group n=46. 
 
Z-scores used to 
derive ‘total deficit 
score’ (range 0-6 
for each test) for 
each patient. Total 
deficit score 
POCD defined 
as summed total 
deficit score of 
≥7.  
 
POCD in 
n=8/75 (10.7%) 
of patients. 
BMI >30 kg/m
2
 
(n=12/75; 16%) 
versus BMI≤30 
kg/m
2
 (n=63/75; 
84%). 
Age, diabetes, 
APOEe4,  
RR 24.43 
(95% CI 1.41, 
422.9). 
17/22 
summed across 
tests. 
Kadoi & 
Goto 
(2006) 
[36] 
 
Japan 
88 80 CABG. 
 
General 
anesthesia. 
62 ± 
11  
6 
months 
Five detailed 
neuropsychological 
tests (Rey Learning 
Test; Trail-Making 
Test A; Trail-
Making Test B; 
Digit Span 
Forward; Grooved 
Pegboard); MMSE. 
Definition of 
POCD unclear. 
 
POCD in 
n=24/88 
(27.3%) of 
patients. 
Body weight as 
continuous per 
kg (mean 56.9 ± 
11** kg).   
Total of 18 
clinical and 
sociodemogra
phic 
covariates.  
RR 1.0 (95% 
CI 0.9, 1.1). 
11/22 
Evered et 
al. (2011) 
[29] 
 
Australia 
443 63 Coronary 
angiography, 
CABG, total hip 
replacement 
surgery. 
 
Local, spinal or 
general 
anesthesia. 
68 ± 
8  
7 days Seven detailed 
neuropsychological 
tests (Auditory 
Verbal Learning 
Test; Digit Symbol 
Substitution Test; 
Trail-Making Test 
A; Trail-Making 
Test B; Controlled 
Oral Word 
Association Test; 
Verbal Fluency; 
Grooved 
Pegboard). For 
each test, 
calculation of RCI: 
(Change score − 
mean change 
score of 
controls)/SD of 
change score of 
controls.  
 
To obtain 
combined z-score, 
scores summed for 
each test and 
divided by SD of 
POCD defined 
as RCI <1.96 on 
≥2 tests and/or 
combined z-
score < -1.96. 
POCD in 
n=150/443 
(33.9%) of 
patients. 
BMI as 
continuous per 
kg/m
2
 (mean 
28.5 ± 5 kg/m
2
). 
Age, diabetes, 
hypercholester
olemia, beta 
blockers, 
statins, PAD, 
MI, type of 
surgery. 
RR 0.98 (95% 
CI 0.93, 1.03). 
16/22 
summed score of 
control group. 
Control group 
n=34.  
Zhu et al. 
(2014) 
[44] 
 
China 
205 51 Total hip 
replacement 
surgery. 
 
Spinal or 
general 
anesthesia. 
75 ± 
6 
 
7 days MMSE. 
 
 
 
POCD defined 
as ≥1 SD 
decline on 
MMSE.  
POCD in 
n=56/205 
(27.3%) of 
patients. 
Body weight as 
continuous per 
kg 
(mean 61.1 ± 11 
kg). 
Age, 
education, 
blood loss, 
hydroxyethyl 
starch 
infusion, 
hemoglobin 
levels, red 
blood cell 
transfusion. 
RR 0.43 (95% 
CI 0.12, 1.37).  
15/22 
Heyer et 
al. (2015) 
[41] 
 
USA 
585 65 Carotid 
endarterectomy.  
 
General 
anesthesia.  
34.4
% 
≥75  
1 day Unclear number of 
neuropsychological 
tests of four 
cognitive domains. 
 
 
For each test, 
calculation of z-
scores: (Change 
score – mean 
change score of 
controls)/SD of 
change score of 
controls. Control 
group n=156.  
POCD defined 
as ≤2 SD worse 
performance in 
2 or more 
cognitive 
domains and/or 
≥1.5 SD worse 
performance in 
all 4 cognitive 
domains.  
POCD in 
n=145/585 
(24.8%) of 
patients. 
BMI >30 kg/m
2 
(n=127/585; 
22%) versus 
BMI≤30 kg/m2 
(n=458/585; 
78%). 
None. RR 1.02 (95% 
CI 0.73, 1.43). 
17/22 
Perez-
Belmonte 
et al. 
(2015) 
[27] 
 
Spain 
36 69 CABG. 
 
Anesthesia 
unreported. 
66 ± 
1  
12 
months 
Six detailed 
neuropsychological 
tests (Trail-Making 
Test; Stroop Test; 
Selective 
Reminding Test; 
Verbal Fluency 
Tests (semantic, 
phonological); 
Judgement of Line 
POCD defined 
as ‘MCI’ 
(percentile rank 
≤10%) or 
‘inferior normal 
function’ 
(percentile rank 
11% to 18%).  
POCD in mean 
31% of patients 
BMI >30 kg/m
2 
(n=14/36; 39%) 
versus BMI≤30 
kg/m
2 
(n=22/36; 
61%). 
None. Original 
reporting of 
RR 1.6 (95% 
CI 1.3, 3.8).  
 
RR 2.14 (95% 
CI 1.3, 3.8) for 
the purpose of 
the present 
analysis.  
11/22 
Orientation Test.  
 
Scores for each 
patient converted to 
norm-compared 
reference scores 
(adjusted for age, 
education). 
(n=11/36) 
across cognitive 
tests. 
APOEe4, apolipoprotein e4 allele; BMI, body mass index; CABG, coronary artery bypass grafting; MCI, mild cognitive impairment; MI, myocardial infarction; MMSE, Mini 
Mental State Examination; PAD, peripheral arterial disease; POCD, post-operative cognitive dysfunction; RCI, Reliable Change Index; RR, risk ratio; SD, standard deviation; 
RCT, randomized controlled trial.  
*based on checklist for cohort studies by STROBE Initiative (2007); maximum score 22. 
**original publication reports SD = 110 kg (assumed to be due to typographical error).  
 
 
  
 
 
 
Figure 1: Flow chart for search on obesity and post-operative 
cognitive dysfunction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2: Summary of studies on obesity and post-operative cognitive dysfunction. Top 
Panel (a): Analysis of studies on body mass index >30 kg/m
2
 versus ≤30 kg/m2. Middle 
Panel (b): Study on body mass index (kg/m
2
). Bottom Panel (c): Analysis of studies on 
body weight (kg) 
 
 
 
 
 Figure 3: Funnel plot of studies on obesity and risk of post-operative 
cognitive dysfunction 
